STRATA Skin Sciences expands distribution agreement with Kosmo Meditech through 2026

STRATA Skin Sciences, Inc.

Agreement with Cutech (Kosmo Meditech parent) extended through December 31, 2026 for direct capital and recurring revenue sales in Korea.
Defined annual and quarterly performance-based purchase requirements, with STRATA becoming sole provider of gas and consumables.
CPT codes 96920-96922 revised effective Jan 1, 2024 to 'Excimer laser treatment for psoriasis', impacting Medicare and potentially private insurers.
STRATA's XTRAC and Pharos are the only excimer laser devices currently marketed in the US that meet the revised code description.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.